Marker Therapeutics Inc (MRKR)

[Rkmatters]

Yes, it is from the NCI. They'll be getting updates on TPIV's work. But that $265k grant issued to Mayo Clinic is for a T-helper vaccine (TH17) to be tested in conjunction with the FRa vaccine in a safety and T cell Phase I response study.

Thus far though NCI paid for the HER2 & FRa Phase Is studies.